pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
650
stories
Jun 17, 26
STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcomm
stat
Jun 17, 26
STAT+: Pharmalittle: We’re reading about hackers extorting Novo, an FDA about-face, and more
stat
Jun 17, 26
Trump administration will bring special ed to HHS
stat
Jun 17, 26
STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approval
stat
Jun 16, 26
FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
biopharma dive
Jun 16, 26
STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
stat
Jun 16, 26
Neumora depression drug fails; EnGene to cut 50% of staff
biopharma dive
Jun 16, 26
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
fda press
Jun 15, 26
FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes
fda press
Jun 15, 26
CMS seeks to close Medicare negotiation 'loophole'
endpoints
Jun 15, 26
STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canada
stat
Jun 15, 26
STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canada
stat
Jun 15, 26
J&J multiple myeloma drug gains edge in earlier stage disease
biopharma dive
Jun 15, 26
STAT+: Lilly’s Ajax acquisition may have been worth it
stat
Jun 13, 26
STAT+: FDA approves Sanofi diabetes drug for children with stage 3 diabetes
stat
Jun 12, 26
Merck brings Welireg-Keytruda combo to treat kidney cancer
endpoints
Jun 12, 26
Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
biopharma dive
Jun 11, 26
Summit pulls $500M share sale a day after announcing it
biopharma dive
Jun 11, 26
Sensorion, citing Regeneron competition, shifts focus to a different hearing loss therapy
biopharma dive
Jun 11, 26
Novartis RNA drug acquired in $12B Avidity deal notches a trial win
biopharma dive
Jun 11, 26
Takeda’s $4B TYK2 drug tops Bristol Myers’ Sotyktu in head-to-head test
biopharma dive
Jun 10, 26
DOJ reaches second settlement on youth gender care
stat
Jun 10, 26
Opinion: Even in abortion-protecting states, teens face unnecessary barriers to care
stat
Jun 9, 26
FDA OKs first new sunscreen ingredient in more than 25 years
stat
Jun 9, 26
Merck, Gilead report mixed outcomes in key lung cancer, HIV studies
biopharma dive
Jun 9, 26
Gilead and Merck’s latest trial success and flop
stat
Jun 9, 26
GSK boosts cancer pipeline with $11B Nuvalent buyout
biopharma dive
Jun 9, 26
GSK to acquire Nuvalent and its two cancer drugs under FDA review for $10.6B
endpoints
Jun 8, 26
Tango data add to growing momentum for pancreatic cancer drugs
biopharma dive
Jun 5, 26
Generic drugmakers gain key victory in ‘skinny label’ patent case
biopharma dive
← prev
page 15 of 22
next →
